DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bactroban (Mupirocin Calcium Topical) - Published Studies


Bactroban Related Published Studies

Well-designed clinical trials related to Bactroban (Mupirocin Topical)

A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis. [2012]

A Randomized Controlled Trial Comparing Mupirocin and Polysporin Triple Ointments in Peritoneal Dialysis Patients: The MP3 Study. [2011.12.01]

The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals. [2010.12]

The NOSE Study (Nasal Ointment for Staphylococcus aureus Eradication): A Randomized Controlled Trial of Monthly Mupirocin in HIV-Infected Individuals. [2010.08.03]

A double-blind, randomized, controlled trial of topical polysporin triple compound versus topical mupirocin for the eradication of colonization with methicillin-resistant Staphylococcus aureus in a complex continuing care population. [2009.09]

Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. [2008.09]


Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial. [2007.10]

Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients. [2007.03]

Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. [2007.01.15]

Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. [2005.05]

Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. [2004.03.16]

A prospective, randomized pilot evaluation of topical triple antibiotic versus mupirocin for the prevention of uncomplicated soft tissue wound infection. [2004.01]

The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience. [2004]

Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. [2003.12.01]

Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery. [2003.09]

The preventive effects of mupirocin against nasotracheal intubation-related bacterial carriage. [2003.07]

[Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections] [2003.06]

A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. [2002.10]

Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. [2002.08.15]

Mupirocin vs terbinafine in impetigo. [2002.08]

Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. [2002.06.13]

A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema. [2002.01]

Reduction in gram-positive pneumonia and antibiotic consumption following the use of a SDD protocol including nasal and oral mupirocin. [2001.09]

A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. [1999.09]

Perianal candidosis--a comparative study with mupirocin and nystatin. [1999.08]

Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. [1999.06]

Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization. [1999.05]

[Endonasal mupirocin in the prevention of nosocomial pneumonia] [1999.03]

Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized, placebo-controlled trial. [1999.01]

Mupirocin cream is as effective as oral cephalexin in the treatment of secondarily infected wounds. [1998.12]

Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. [1998.06]

A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. [1996.05.27]

A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. [1996.05]

A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel. [1995.03]

Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. [1995.01]

Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. [1994.07.11]

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group. [1993.09]

Treatment of familial staphylococcal infection--comparison of mupirocin nasal ointment and chlorhexidine/neomycin (Naseptin) cream in eradication of nasal carriage. [1993.06]

Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. [1992.04]

Mupirocin treatment of nasal staphylococcal colonization. [1992.02]

Cost-effectiveness of erythromycin versus mupirocin for the treatment of impetigo in children. [1992.02]

Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. [1992.02]

Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin. [1992]

Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. [1991.01.15]

Use of mupirocin ointment in the treatment of secondarily infected dermatoses. [1990.05]

A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo. [1990.05]

Mupirocin for the reduction of colonization of internal jugular cannulae--a randomized controlled trial. [1990.05]

Effect of mupirocin on nasal carriage of Staphylococcus aureus. [1989.08]

Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. [1989.08]

Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections. [1989.06]

Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin. [1989.06]

Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate. [1989.05]

Randomized clinical trial of topical mupirocin versus oral erythromycin for impetigo. [1988.12]

Topical mupirocin vs. systemic erythromycin treatment for pyoderma. [1988.11]

Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. [1988.08]

[Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections] [1988]

Well-designed clinical trials possibly related to Bactroban (Mupirocin Topical)

Randomized comparison of 2 protocols to prevent acquisition of methicillin-resistant Staphylococcus aureus: results of a 2-center study involving 500 patients. [2011.11]

Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial. [2011.09]

Effects of external application of Chinese medicine on diabetic ulcers and the expressions of beta-catenin, c-myc and K6. [2011.04]

[Does nasal decontamination reduce the incidence of infections after cardiac surgery?] [2010.04]

Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. [2010.01.07]

The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. [2009.05]

Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. [2009.05]

Clinical outcomes in peritoneal dialysis: impact of continuous quality provement initiatives. [2009]

Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. [2008.05]

Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: Diagnosis and treatment. [2008.03]

Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. [2007.09]

Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. [2006.10]

Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. [2006.10]

Randomized clinical trial of the effect of applying ointment to surgical wounds before occlusive dressing. [2006.08]

Prevention of acquired infections in intubated patients with the combination of two decontamination regimens. [2005.02]

Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. [2005.02]

[Perioperative nosocomial infection preventive measures] [2004.11]

A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. [2004.04]

Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis. [2003.11]

Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. [2000.12]

The treatment of Staphyloccocus aureus infected sore nipples: a randomized comparative study. [1999.09]

Eradication of nasal carriage of Staphylococcus aureus--is it cost-effective? [1998.09]

Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. [1996.12]

Nasal and hand carriage of Staphylococcus aureus in healthcare workers. [1994.04]

Other research related to Bactroban (Mupirocin Topical)

Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. [2014]

Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization. [2013]

Increased peritoneal dialysis exit site infections using topical antiseptic polyhexamethylene biguanide compared to mupirocin: results of a safety interim analysis of an open-label prospective randomized study. [2013]

Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. [2013]

A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study. [2012]

Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. [2011.06.15]

Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. [2011.05]

Clinical and cost ineffectiveness of preoperative screening for methicillin-resistant Staphylococcus aureus and intranasal mupirocin in preventing methicillin-resistant S aureus infections in cardiothoracic surgery. [2011.04]

Auditory function after application of ototopical vancomycin and mupirocin solutions in a murine model. [2011.03]

A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains. [2011.02]

Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States. [2011.01]

Dynamic of nasal colonization by methicillin-resistant Staphylococcus aureus ST398 and ST1 after mupirocin treatment in a family in close contact with pigs. [2011.01]

Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus. [2010.11]

Mupirocin resistance in clinical isolates of staphylococci in a tertiary care centre in south India. [2010.10]

Dynamic of nasal colonization by methicillin-resistant Staphylococcus aureus ST398 and ST1 after mupirocin treatment in a family in close contact with pigs. [2010.07.19]

Multicenter study to determine disk diffusion and broth microdilution criteria for prediction of high- and low-level mupirocin resistance in Staphylococcus aureus. [2010.07]

Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population. [2010.07]

Staphylococcus aureus bacteremia and buttonhole cannulation: long-term safety and efficacy of mupirocin prophylaxis. [2010.06]

Resistance to and synthesis of the antibiotic mupirocin. [2010.04]

Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. [2010.02]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017